P rogressive chronic liver disease often causes neurological manifestation, including hepatic encephalopathy )HE(, acquired hepatocerebral degeneration )AHD(, and hepatic myelopathy )HM(. Among these dysfunctions, HE is the most common and reversible disorder, while AHD is a rare and irreversible syndrome. Hepatic encephalopathy is a serious complication of liver disease and is characterized by neuropsychiatric symptoms, which range from subtle neurocognitive alterations to severe life-threatening neurological impairment.
P rogressive chronic liver disease often causes neurological manifestation, including hepatic encephalopathy )HE(, acquired hepatocerebral degeneration )AHD(, and hepatic myelopathy )HM(. Among these dysfunctions, HE is the most common and reversible disorder, while AHD is a rare and irreversible syndrome. Hepatic encephalopathy is a serious complication of liver disease and is characterized by neuropsychiatric symptoms, which range from subtle neurocognitive alterations to severe life-threatening neurological impairment. 1, 2 Hepatic encephalopathy presents in as many as 28% of patients with liver cirrhosis, and can be alleviated by lowering the blood ammonia levels.
1,2 However, AHD is rare and the best result among the possible treatments is orthotopic liver transplantation. 3 The prevalence of this disease is between 0.8-2% of cirrhotic patients. Of note, the more relevant risk factors are the presence of portosystemic shunts and the multiple bouts of hepatic coma seen in some patients with HE. 4, 5 Acquired hepatocerebral degeneration is a progressive, irreversible neurological syndrome caused by persistent and decompensated liver disease, and characterized by abnormal movements, dysarthria, rigidity, intention tremor, ataxia, and impairment of intellectual functions. 6 In AHD physiopathology, manganese accumulation in the basal nuclei appears to be a key factor. This metal concentration is responsible for the MRI T1 hyperintensity mainly involving the basal ganglia, which can be considered a biomarker of manganese overload. 3, 6 Hepatic encephalopathy and AHD are 2 different CNS disorders secondary to hepatic dysfunction. Hyperkinetic extrapyramidal syndrome is the typical clinical characteristic of AHD, but usually not observed in HE. Here, we describe a case coexisting with HE and AHD in the presence of symmetrical basal ganglia high signal intensity on T1-weighted images and widespread T2 high signal intensity of the hemispheric white matter. Our objective in presenting this particular case is to highlight the presence of AHD that is considered rare as the diagnosis tends to be ignored. Case Report. A 65-year-old woman with cirrhosis due to hepatitis C infection was submitted for a splenectomy in 2011 in order to control an upper gastrointestinal bleed. Since 2012, she had at least 3 episodes of mental and behavioral disorders, which were alleviated by lowering the blood ammonia. She had progressive bradykinesia and dysarthria, which could not be mitigated by common therapy. Before her first visit to our hospital, the extrapyramidal symptoms worsened. In April, 2013, she fell into a coma after a high protein diet, and was admitted to our hospital for further treatment. In the emergency room, serum electrolytes, serum glucose, and the renal function tests were normal, while the hepatic tests were as follows: and symmetrical T1 high-intensity of the basal ganglia ( Figure 1A ) associated with widespread high-signal intensity of the brain hemispheric white matter on fast T2 and T2-FLAIR sequences (Figures 1B & 1C) without diffusivity restriction )high signal intensity on the apparent diffusion coefficient [ADC] map( indicating that the signal abnormality corresponded to interstitial edema (Figures 1D & 1E) . From these clinical and laboratory findings, the diagnosis could be limited to liver cirrhosis, hepatitis C, and HE. After conventional HE treatment, her level of consciousness recovered on the fourth day. However, as she already had signs of AHD according to the MRI exams, the diagnosis of AHD was also considered, and she maintained the extrapyramidal symptoms. Accordingly, as in this patient HE coexisted with AHD, these findings remind us that these 2 conditions can be found in the same patient, and the diagnosis of AHD must be made as soon as possible due to the severity of the disease.
Discussion. The classical pathogenesis of HE is the ammonia accumulation in the blood, thus orthotopic liver transplantation, the flow interruption in portosystemic shunts should be considered to avoid the development of neurological sequelae.
reaching the CNS. 1 The T2 hyperintensity seen on T2-weighted images is a common finding in patients with HE. The lesions can be observed on the cortex or in a diffuse pattern on the white matter, and may be related to the focal injuries caused by increased ammonia concentration. 7 On the other hand, the AHD pathogenesis still has some unknown components. The high-intensity pattern on the basal ganglia seen on T1-weighted sequences at MRI suggests the diagnosis of AHD. 8 Liver failure seems to be directly responsible for the manganese accumulation, which may contribute to the extrapyramidal symptoms. 6 The bilateral and symmetric T1 high-intensity alterations involving the globus pallidus are often observed in AHD because of the manganese deposition. 6 In this case, the patient had hepatitis C infection and liver cirrhosis, and the consciousness impairment was caused by HE. Thus, it was alleviated after lowering the serum ammonia levels. The widespread white matter signal abnormalities likely reflecting interstitial edema (Figures 1B-1E ) was considered as a result of the toxic involvement related to the liver disease, and ammonia is probably implicated in its development. 9 Thus, the progressive development of extrapyramidal symptoms was a characteristic feature of AHD. Moreover, the bilateral globus pallidus hyperintensity on T1-weighted images was also a typical AHD finding, leading to the diagnosis of AHD associated to HE.
To date there is no consensus on whether repeated HE episodes constitute a key factor in AHD development. 10 Thus, it is still a challenge to distinguish AHD from HE, especially when these 2 disorders coexist. We should learn more to guide early intervention and treatment, especially from the noninvasive and objective MRI findings. Although the pathogenesis of AHD remains partially unknown and shares some aspects with HE, it is important to realize that AHD is a more severe disease. Therefore, more attention should be focused on preventing such diseases, and physicians must be aware that the lack of response after HE treatment can be a clue for AHD. For patients who could not be submitted to
